UBS Group’s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS DRGS Stock Holding History

UBS Group’s Portfolio DRGS Stock Details DRGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-89	Closed	-$5K	–	9219
2015 Q1	$5K	Sell	89 -161	-64%	-$9.19K	﹤0.01%	8177
2014 Q4	$13K	Buy	+250	New	+$13K	﹤0.01%	8189

Other funds holding DRGS

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

UBS Group's DRGS Position: Q2 2015 in Review

UBS Group sold out of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) in Q2 2015, closing a stake of 89 shares — an estimated $5K sold.

UBS Group first reported a position in DRGS in Q4 2014 and held it in 2 quarters. The position peaked at $13K in Q4 2014. 3 funds tracked by Wall St. Rank hold DRGS as of Q2 2015.

UBS Group reported no remaining RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position as of Q2 2015 after selling out during the quarter.
UBS Group sold 89 RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS shares in Q2 2015, an estimated $5K.
UBS Group first reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in Q4 2014 and held it in 2 quarters.
UBS Group's RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position peaked at $13K in Q4 2014.
3 funds tracked by Wall St. Rank held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS as of Q2 2015.

Based on UBS Group's 13F filing for Q2 2015, filed 14 Aug 2015.